Utah Medical Products Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 109 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Utah Medical Products Inc is 9.56, ranking 2 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 8.72M, representing a year-over-year decrease of 10.18%, while its net profit experienced a year-over-year decrease of 14.37%.
Key Metrics
The current valuation score of Utah Medical Products Inc is 8.45, ranking 19 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 18.73, which is 18.25% below the recent high of 22.14 and 27.01% above the recent low of 13.67.
No earnings forecast score is currently available for Utah Medical Products Inc. The Healthcare Equipment & Supplies industry's average is 7.80.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Utah Medical Products Inc is 6.59, ranking 114 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 69.22 and the support level at 59.97, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Utah Medical Products Inc is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 76.75%, representing a quarter-over-quarter increase of 8.51%. The largest institutional shareholder is Brandes Investmen, holding a total of 351.32K shares, representing 11.03% of shares outstanding, with 47.90% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Utah Medical Products Inc is 5.85, ranking 71 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.37. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Utah Medical Products Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
